The Experts below are selected from a list of 5442 Experts worldwide ranked by ideXlab platform

Robert H Dworkin - One of the best experts on this subject based on the ideXlab platform.

  • validation of the short form McGill Pain Questionnaire 2 sf mpq 2 in acute low back Pain
    The Journal of Pain, 2015
    Co-Authors: Robert H Dworkin, Dennis C Turk, Jeremiah J Trudeau, Carmela Benson, David M Biondi, Nathaniel P Katz, Myoung Kim
    Abstract:

    Abstract The Short-form McGill Pain Questionnaire (SF-MPQ-2) assesses the major symptoms of both neuropathic and nonneuropathic Pain and can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response. Previous research has demonstrated its reliability, validity, and responsiveness in diverse samples of patients with chronic Pain. However, the SF-MPQ-2 has not been evaluated for use in patients with acute Pain. Data were examined from a double-blind, randomized clinical trial of immediate-release tapentadol versus immediate-release oxycodone in patients with acute low back and associated radicular leg Pain (N = 666). Analyses of internal consistency, convergent validity, and confirmatory factor structure were conducted using baseline data, and analyses of responsiveness were conducted using baseline and endpoint data. The SF-MPQ-2 total score and its 4 subscale scores (continuous Pain, intermittent Pain, predominantly neuropathic Pain, and affective descriptors) generally showed good psychometric properties and 1) were internally consistent, 2) displayed good convergent validity, 3) fit the a priori factor structure, and 4) were highly responsive to analgesic treatment. These data extend previous evidence of the reliability, validity, and responsiveness of the SF-MPQ-2 in patients with chronic Pain to those with acute low back and associated radicular leg Pain. Perspective Considered together with the results of other recent studies, the data suggest that the SF-MPQ-2 can provide a valid, responsive, and efficient assessment of both neuropathic and nonneuropathic Pain qualities for clinical trials and other clinical research examining patients with various acute and chronic Pain conditions.

  • validation of the short form McGill Pain Questionnaire 2 in younger and older people with cancer Pain
    The Journal of Pain, 2014
    Co-Authors: Lynn R Gauthier, Alycia Young, Robert H Dworkin, Gary Rodin, Camilla Zimmermann, David Warr, Lawrence S Librach
    Abstract:

    Abstract Pain is among the most common symptoms of cancer. Because cancer can occur at any age, it is imperative that Pain assessment tools are valid for use across the adult lifespan. The Short-Form McGill Pain Questionnaire–2 (SF-MPQ-2) is a valid and reliable tool for the assessment of the multidimensional qualities of Pain in people with chronic nonmalignant Pain, but its psychometric properties in people with cancer Pain and in older versus younger people require investigation. This study evaluated age differences in the validity, reliability, and use of the SF-MPQ-2 in 244 people with advanced cancer and Pain. We confirmed the previously reported 4-factor solution in older (≥60 years) and younger ( Perspective This study demonstrated that the SF-MPQ-2 is valid for use in older and younger people with advanced cancer and Pain. This measure could improve cancer Pain assessment across the adult lifespan, which may lead to improved Pain management.

  • development and initial validation of an expanded and revised version of the short form McGill Pain Questionnaire sf mpq 2
    Pain, 2009
    Co-Authors: Robert H Dworkin, Dennis C Turk, Dennis A Revicki, Gale Harding, Karin S Coyne, Sarah Peircesandner, Dileep Bhagwat, Dennis Everton, Laurie B Burke, Penney Cowan
    Abstract:

    The objective of the present research was to develop a single measure of the major symptoms of both neuropathic and non-neuropathic Pain that can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response. We expanded and revised the Short-form McGill Pain Questionnaire (SF-MPQ) Pain descriptors by adding symptoms relevant to neuropathic Pain and by modifying the response format to a 0-10 numerical rating scale to provide increased responsiveness in longitudinal studies and clinical trials. The reliability, validity, and subscale structure of the revised SF-MPQ (SF-MPQ-2) were examined in responses from 882 individuals with diverse chronic Pain syndromes and in 226 patients with Painful diabetic peripheral neuropathy who participated in a randomized clinical trial. The data suggest that the SF-MPQ-2 has excellent reliability and validity, and the results of both exploratory and confirmatory factor analyses provided support for four readily interpretable subscales-continuous Pain, intermittent Pain, predominantly neuropathic Pain, and affective descriptors. These results provide a basis for use of the SF-MPQ-2 in future clinical research, including clinical trials of treatments for neuropathic and non-neuropathic Pain conditions.

Joy C Macdermid - One of the best experts on this subject based on the ideXlab platform.

  • reproducibility reliability and agreement parameters of the revised short McGill Pain Questionnaire version 2 for use in patients with musculoskeletal shoulder Pain
    Canadian Journal of Pain = Revue Canadienne de la Douleur, 2020
    Co-Authors: Samuel U Jumbo, Joy C Macdermid, Tara L Packham, George S Athwal, Kenneth J Faber
    Abstract:

    Background: The Revised Short-Form McGill Pain Questionnaire Version-2 (SF-MPQ-2) is a multidimensional outcome measure designed to evaluate neuropathic and nonneuropathic Pain. A recent systematic...

  • measurement properties of the brief Pain inventory short form bpi sf and the revised short McGill Pain Questionnaire version 2 sf mpq 2 in Pain related musculoskeletal conditions a systematic review protocol
    The archives of bone and joint surgery, 2020
    Co-Authors: Samuel U Jumbo, Joy C Macdermid, Michael E Kalu, Tara L Packham, George S Athwal, Kenneth J Faber
    Abstract:

    Background: The Brief Pain Inventory-Short Form (BPI-SF) and Revised Short-Form McGill Pain Questionnaire Version-2(SF-MPQ-2) are generic Pain assessment tools used in research and practice for Pain assessment in musculoskeletal(MSK) conditions. A comprehensive review that systematically analyses their measurement properties in MSK conditionshas not been performed. This review protocol describes the steps that will be taken to locate, critically appraise, compareand summarize clinical measurement research on the BPI-SF and SF-MPQ-2 in Pain-related MSK conditions.Methods: Medline, EMBASE, CINAHL and Scopus will be searched for publications that examine the measurementproperties of the Brief Pain Inventory and Revised Short-Form McGill Pain Questionnaire Version-2. Two reviewerswill independently screen citations (title, abstract and full text) and extract relevant data. The extensiveness, rigor,and quality of measurement property reports will be examined with a structured measurement studies appraisal tool,and with the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN)guidelines. Findings will be descriptively summarized, and when possible, a meta-analysis will be performed.Discussion: This review will summarize and compare the current level of evidence on the measurement properties of theBPI-SF and SF-MPQ-2 in a spectrum of musculoskeletal conditions. We expect clinicians/researchers dealing with MSKconditions to have synthesized evidence that informs their decision making and preferences. In addition, the review hopesto identify gaps and determine priorities for future research with or on the BPI-SF and SF-MPQ-2 in MSK conditions.Level of evidence: Not Applicable

  • ab1328 measurement properties of the brief Pain inventory short form bpi sf and the revised short form McGill Pain Questionnaire version 2 sf mpq 2 in Pain related musculoskeletal conditions a systematic review
    Annals of the Rheumatic Diseases, 2019
    Co-Authors: Joy C Macdermid, Samuel U Jumbo, Michael E Kalu, Tara L Packham, George S Athwal, Ken Faber
    Abstract:

    Background The Brief Pain Inventory (BPF-SF) and McGill Pain Questionnaire (SF-MPQ-2) are general-use, self-report, multidimensional Pain assessment outcomes frequently used for Pain assessment in musculoskeletal (MSK) conditions. Synthesizing knowledge on their measurement properties, as assessed in MSK conditions, should provide a deeper understanding of their strengths and limitations. Objectives To systematically locate, critically appraise, compare and summarize clinical measurement research about the BPI-SF and SF-MPQ-2 in Pain-related musculoskeletal conditions Methods Four databases (Medline, CINAHL, EMBASE & SCOPUS) were systematically searched for relevant citations, each for the BPI-SF and SF-MPQ-2. We included articles that reported the psychometric properties (e.g. validity, reliability, responsiveness) and interpretability indices (e.g. minimal clinical important difference) of both tools, as assessed in mixed and specific MSK studies. Independently, two reviewers extracted data and assessed the quality of evidence with a structured quality assessment tool for measurement studies and according to the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Results Twenty-five articles were included (BPI-SF, n=17; SF-MPQ-2, n=8). Both tools lack reporting on their cross-cultural validities and measurement error indices. High quality studies suggest that they are internally consistent (α = 0.83-0.96), and they associate modestly with similar outcome measures (r = 0.3-0.69). There is evidence that the BPI-SF conforms to its two-dimensional structure in MSK studies; the SF-MPQ-2 four-factor structure was not clearly established. In seven reports, high to moderate quality evidence was seen in supports of the BPI-SF known group validity (n=2) and responsiveness (n=5) but none was available for the SF-MPQ-2. Furthermore, the SF-MPQ-2 was more frequently associated with floor effects in MSK studies than the BPI-SF (SF-MPQ-2, 42% vs BPI-SF, 6%). Conclusion The SF-MPQ-2 has emeging evidence whereas the BPI-SF evidence is more mature. Both tools displayed high-quality evidence in support of their internal consistency and criterion-convergent validities. High to moderate quality evidence suggests the BPI-SF subscales have a better responsiveness, retest reliability, known group validity and structural validity than the SF-MPQ-2. References [1] Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129-138. doi:10.1016/0029-7844(94)00457-O. [2] Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1):35-42. doi:10.1016/j.Pain.2009.02.007. [3] Dworkin RH, Turk DC, Trudeau JJ, et al. Validation of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Acute Low Back Pain. J Pain. 2015;16(4):357-366. doi:10.1016/j.jPain.2015.01.012. Disclosure of Interests None declared

Ken Faber - One of the best experts on this subject based on the ideXlab platform.

  • ab1328 measurement properties of the brief Pain inventory short form bpi sf and the revised short form McGill Pain Questionnaire version 2 sf mpq 2 in Pain related musculoskeletal conditions a systematic review
    Annals of the Rheumatic Diseases, 2019
    Co-Authors: Joy C Macdermid, Samuel U Jumbo, Michael E Kalu, Tara L Packham, George S Athwal, Ken Faber
    Abstract:

    Background The Brief Pain Inventory (BPF-SF) and McGill Pain Questionnaire (SF-MPQ-2) are general-use, self-report, multidimensional Pain assessment outcomes frequently used for Pain assessment in musculoskeletal (MSK) conditions. Synthesizing knowledge on their measurement properties, as assessed in MSK conditions, should provide a deeper understanding of their strengths and limitations. Objectives To systematically locate, critically appraise, compare and summarize clinical measurement research about the BPI-SF and SF-MPQ-2 in Pain-related musculoskeletal conditions Methods Four databases (Medline, CINAHL, EMBASE & SCOPUS) were systematically searched for relevant citations, each for the BPI-SF and SF-MPQ-2. We included articles that reported the psychometric properties (e.g. validity, reliability, responsiveness) and interpretability indices (e.g. minimal clinical important difference) of both tools, as assessed in mixed and specific MSK studies. Independently, two reviewers extracted data and assessed the quality of evidence with a structured quality assessment tool for measurement studies and according to the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Results Twenty-five articles were included (BPI-SF, n=17; SF-MPQ-2, n=8). Both tools lack reporting on their cross-cultural validities and measurement error indices. High quality studies suggest that they are internally consistent (α = 0.83-0.96), and they associate modestly with similar outcome measures (r = 0.3-0.69). There is evidence that the BPI-SF conforms to its two-dimensional structure in MSK studies; the SF-MPQ-2 four-factor structure was not clearly established. In seven reports, high to moderate quality evidence was seen in supports of the BPI-SF known group validity (n=2) and responsiveness (n=5) but none was available for the SF-MPQ-2. Furthermore, the SF-MPQ-2 was more frequently associated with floor effects in MSK studies than the BPI-SF (SF-MPQ-2, 42% vs BPI-SF, 6%). Conclusion The SF-MPQ-2 has emeging evidence whereas the BPI-SF evidence is more mature. Both tools displayed high-quality evidence in support of their internal consistency and criterion-convergent validities. High to moderate quality evidence suggests the BPI-SF subscales have a better responsiveness, retest reliability, known group validity and structural validity than the SF-MPQ-2. References [1] Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129-138. doi:10.1016/0029-7844(94)00457-O. [2] Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1):35-42. doi:10.1016/j.Pain.2009.02.007. [3] Dworkin RH, Turk DC, Trudeau JJ, et al. Validation of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Acute Low Back Pain. J Pain. 2015;16(4):357-366. doi:10.1016/j.jPain.2015.01.012. Disclosure of Interests None declared

Dennis C Turk - One of the best experts on this subject based on the ideXlab platform.

  • validation of the short form McGill Pain Questionnaire 2 sf mpq 2 in acute low back Pain
    The Journal of Pain, 2015
    Co-Authors: Robert H Dworkin, Dennis C Turk, Jeremiah J Trudeau, Carmela Benson, David M Biondi, Nathaniel P Katz, Myoung Kim
    Abstract:

    Abstract The Short-form McGill Pain Questionnaire (SF-MPQ-2) assesses the major symptoms of both neuropathic and nonneuropathic Pain and can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response. Previous research has demonstrated its reliability, validity, and responsiveness in diverse samples of patients with chronic Pain. However, the SF-MPQ-2 has not been evaluated for use in patients with acute Pain. Data were examined from a double-blind, randomized clinical trial of immediate-release tapentadol versus immediate-release oxycodone in patients with acute low back and associated radicular leg Pain (N = 666). Analyses of internal consistency, convergent validity, and confirmatory factor structure were conducted using baseline data, and analyses of responsiveness were conducted using baseline and endpoint data. The SF-MPQ-2 total score and its 4 subscale scores (continuous Pain, intermittent Pain, predominantly neuropathic Pain, and affective descriptors) generally showed good psychometric properties and 1) were internally consistent, 2) displayed good convergent validity, 3) fit the a priori factor structure, and 4) were highly responsive to analgesic treatment. These data extend previous evidence of the reliability, validity, and responsiveness of the SF-MPQ-2 in patients with chronic Pain to those with acute low back and associated radicular leg Pain. Perspective Considered together with the results of other recent studies, the data suggest that the SF-MPQ-2 can provide a valid, responsive, and efficient assessment of both neuropathic and nonneuropathic Pain qualities for clinical trials and other clinical research examining patients with various acute and chronic Pain conditions.

  • evaluation of the psychometric properties of the revised short form McGill Pain Questionnaire
    The Journal of Pain, 2012
    Co-Authors: T Lovejoy, Dennis C Turk, Benjamin J Morasco
    Abstract:

    Abstract The recently revised version of the Short-Form McGill Pain Questionnaire (SF-MPQ-2) was created to assess both neuropathic and non-neuropathic Pain. The current study extends prior research by testing the reliability and validity of the SF-MPQ-2 in a sample of U.S. veteran patients with a range of chronic Pain diagnoses. Participants (N = 186) completed the SF-MPQ-2, a sociodemographic Questionnaire, the Structured Clinical Interview for the DSM-IV, and self-report Pain and psychiatric measures. Pain diagnoses were extracted from the electronic medical record. The SF-MPQ-2 total and scale scores demonstrated good-to-excellent internal consistency. Convergent and discriminant validity were supported, and SF-MPQ-2 total and scale scores increased with number of Pain diagnoses and Pain severity. Confirmatory factor analyses indicated that a 4-factor model fit the data better than a single-factor model. However, high intercorrelations among the 4 latent constructs were observed, and a second-order global Pain construct also emerged. Overall, the SF-MPQ-2 demonstrated excellent reliability and validity in a sample of U.S. veteran patients with chronic neuropathic and non-neuropathic Pain. Future psychometric studies of the SF-MPQ-2 should employ longitudinal data to evaluate the ability of scale scores to uniquely predict clinical and health service outcomes. Perspective This article presents the psychometric properties of a revised version of the SF-MPQ-2. This measure may have great utility as a screening tool in clinical practice and as an outcome measure in clinical trials.

  • development and initial validation of an expanded and revised version of the short form McGill Pain Questionnaire sf mpq 2
    Pain, 2009
    Co-Authors: Robert H Dworkin, Dennis C Turk, Dennis A Revicki, Gale Harding, Karin S Coyne, Sarah Peircesandner, Dileep Bhagwat, Dennis Everton, Laurie B Burke, Penney Cowan
    Abstract:

    The objective of the present research was to develop a single measure of the major symptoms of both neuropathic and non-neuropathic Pain that can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response. We expanded and revised the Short-form McGill Pain Questionnaire (SF-MPQ) Pain descriptors by adding symptoms relevant to neuropathic Pain and by modifying the response format to a 0-10 numerical rating scale to provide increased responsiveness in longitudinal studies and clinical trials. The reliability, validity, and subscale structure of the revised SF-MPQ (SF-MPQ-2) were examined in responses from 882 individuals with diverse chronic Pain syndromes and in 226 patients with Painful diabetic peripheral neuropathy who participated in a randomized clinical trial. The data suggest that the SF-MPQ-2 has excellent reliability and validity, and the results of both exploratory and confirmatory factor analyses provided support for four readily interpretable subscales-continuous Pain, intermittent Pain, predominantly neuropathic Pain, and affective descriptors. These results provide a basis for use of the SF-MPQ-2 in future clinical research, including clinical trials of treatments for neuropathic and non-neuropathic Pain conditions.

Samuel U Jumbo - One of the best experts on this subject based on the ideXlab platform.

  • reproducibility reliability and agreement parameters of the revised short McGill Pain Questionnaire version 2 for use in patients with musculoskeletal shoulder Pain
    Canadian Journal of Pain = Revue Canadienne de la Douleur, 2020
    Co-Authors: Samuel U Jumbo, Joy C Macdermid, Tara L Packham, George S Athwal, Kenneth J Faber
    Abstract:

    Background: The Revised Short-Form McGill Pain Questionnaire Version-2 (SF-MPQ-2) is a multidimensional outcome measure designed to evaluate neuropathic and nonneuropathic Pain. A recent systematic...

  • measurement properties of the brief Pain inventory short form bpi sf and the revised short McGill Pain Questionnaire version 2 sf mpq 2 in Pain related musculoskeletal conditions a systematic review protocol
    The archives of bone and joint surgery, 2020
    Co-Authors: Samuel U Jumbo, Joy C Macdermid, Michael E Kalu, Tara L Packham, George S Athwal, Kenneth J Faber
    Abstract:

    Background: The Brief Pain Inventory-Short Form (BPI-SF) and Revised Short-Form McGill Pain Questionnaire Version-2(SF-MPQ-2) are generic Pain assessment tools used in research and practice for Pain assessment in musculoskeletal(MSK) conditions. A comprehensive review that systematically analyses their measurement properties in MSK conditionshas not been performed. This review protocol describes the steps that will be taken to locate, critically appraise, compareand summarize clinical measurement research on the BPI-SF and SF-MPQ-2 in Pain-related MSK conditions.Methods: Medline, EMBASE, CINAHL and Scopus will be searched for publications that examine the measurementproperties of the Brief Pain Inventory and Revised Short-Form McGill Pain Questionnaire Version-2. Two reviewerswill independently screen citations (title, abstract and full text) and extract relevant data. The extensiveness, rigor,and quality of measurement property reports will be examined with a structured measurement studies appraisal tool,and with the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN)guidelines. Findings will be descriptively summarized, and when possible, a meta-analysis will be performed.Discussion: This review will summarize and compare the current level of evidence on the measurement properties of theBPI-SF and SF-MPQ-2 in a spectrum of musculoskeletal conditions. We expect clinicians/researchers dealing with MSKconditions to have synthesized evidence that informs their decision making and preferences. In addition, the review hopesto identify gaps and determine priorities for future research with or on the BPI-SF and SF-MPQ-2 in MSK conditions.Level of evidence: Not Applicable

  • ab1328 measurement properties of the brief Pain inventory short form bpi sf and the revised short form McGill Pain Questionnaire version 2 sf mpq 2 in Pain related musculoskeletal conditions a systematic review
    Annals of the Rheumatic Diseases, 2019
    Co-Authors: Joy C Macdermid, Samuel U Jumbo, Michael E Kalu, Tara L Packham, George S Athwal, Ken Faber
    Abstract:

    Background The Brief Pain Inventory (BPF-SF) and McGill Pain Questionnaire (SF-MPQ-2) are general-use, self-report, multidimensional Pain assessment outcomes frequently used for Pain assessment in musculoskeletal (MSK) conditions. Synthesizing knowledge on their measurement properties, as assessed in MSK conditions, should provide a deeper understanding of their strengths and limitations. Objectives To systematically locate, critically appraise, compare and summarize clinical measurement research about the BPI-SF and SF-MPQ-2 in Pain-related musculoskeletal conditions Methods Four databases (Medline, CINAHL, EMBASE & SCOPUS) were systematically searched for relevant citations, each for the BPI-SF and SF-MPQ-2. We included articles that reported the psychometric properties (e.g. validity, reliability, responsiveness) and interpretability indices (e.g. minimal clinical important difference) of both tools, as assessed in mixed and specific MSK studies. Independently, two reviewers extracted data and assessed the quality of evidence with a structured quality assessment tool for measurement studies and according to the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Results Twenty-five articles were included (BPI-SF, n=17; SF-MPQ-2, n=8). Both tools lack reporting on their cross-cultural validities and measurement error indices. High quality studies suggest that they are internally consistent (α = 0.83-0.96), and they associate modestly with similar outcome measures (r = 0.3-0.69). There is evidence that the BPI-SF conforms to its two-dimensional structure in MSK studies; the SF-MPQ-2 four-factor structure was not clearly established. In seven reports, high to moderate quality evidence was seen in supports of the BPI-SF known group validity (n=2) and responsiveness (n=5) but none was available for the SF-MPQ-2. Furthermore, the SF-MPQ-2 was more frequently associated with floor effects in MSK studies than the BPI-SF (SF-MPQ-2, 42% vs BPI-SF, 6%). Conclusion The SF-MPQ-2 has emeging evidence whereas the BPI-SF evidence is more mature. Both tools displayed high-quality evidence in support of their internal consistency and criterion-convergent validities. High to moderate quality evidence suggests the BPI-SF subscales have a better responsiveness, retest reliability, known group validity and structural validity than the SF-MPQ-2. References [1] Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129-138. doi:10.1016/0029-7844(94)00457-O. [2] Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1):35-42. doi:10.1016/j.Pain.2009.02.007. [3] Dworkin RH, Turk DC, Trudeau JJ, et al. Validation of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Acute Low Back Pain. J Pain. 2015;16(4):357-366. doi:10.1016/j.jPain.2015.01.012. Disclosure of Interests None declared